查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1682024

2025年全球心血管植入市場報告

Cardiovascular Implants Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年心血管植入市場規模將強勁成長。到 2029 年，這一數字將成長至 366.9 億美元，年複合成長率(CAGR)為 6.2%。預測期內的成長可歸因於個人化醫療方法、對微創手術的關注、心血管研究的全球合作、強調預防干涉的醫療保健政策以及以患者為中心的心血管護理。預測期內的關鍵趨勢包括藥物釋放型支架的進步、下一代心臟瓣膜的興起、人工智慧 (AI) 的日益融合、對微創植入技術的重視、個性化的患者特定植入以及無導線心律調節器的發展。

預計未來幾年心臟病患病率的不斷上升將推動心血管植入市場的成長。心臟病包括影響心臟和血管的各種疾病，包括冠狀動脈疾病、心臟衰竭、心律不整和瓣膜疾病。冠狀動脈疾病和心臟衰竭等心臟病的發生率上升，刺激了對心血管植入（包括支架和心律調節器）的需求。這些植入有助於支持心臟功能和循環、調節心律並監測心臟衰竭患者的心臟活動。例如，2024 年 9 月，致力於資助研究和提高人們對心臟和循環系統疾病認知的英國慈善機構英國心臟基金會 (BHF) 報告稱，英國約有 760 萬人患有心臟和循環系統疾病。到 2030 年，這一數字可能會增加 100 萬，到 2040 年可能再增加 200 萬。因此，心臟病患病率的上升正在推動心血管植入市場的發展。

預計未來幾年老齡人口的增加將推動心血管植入市場的成長。老化反映了人口結構的變化，其特徵是 60 歲或以上人口比例上升。心血管植入在管理和治療老年人心血管疾病方面發揮關鍵作用，有助於提高生活品質、延長壽命和整體健康。根據世界衛生組織（WHO）2022年10月的預測，到2030年，全球整體六分之一的人將超過60歲，預計2050年將達到21億人。因此，老齡人口的增加是推動心血管植入市場成長的關鍵因素。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場 - 宏觀經濟情景，包括利率、通膨、地緣政治、新冠疫情以及復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球心血管植入PESTEL分析（政治、社會、科技、環境、法律因素、促進因素、限制因素）
  • 最終用途產業分析
  • 全球心血管植入市場：成長率分析
  • 全球心血管植入市場表現：規模與成長，2019-2024
  • 全球心血管植入市場預測：2024-2029年及2034年規模與成長
  • 全球心血管植入總目標市場（TAM）

第6章市場區隔

  • 全球心血管植入市場：依產品、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 冠狀動脈支架
  • 植入式心臟整流去顫器（ICD）
  • 心臟瓣膜
  • 植入式心臟心律調節器
  • 心臟再同步治療 (CRT) 設備
  • 外周支架
  • 全球心血管植入市場（按材料、性能及預測）：2019-2024 年、2024-2029 年、2034 年
  • 金屬和合金
  • 聚合物
  • 生物材料
  • 全球心血管植入市場：依應用、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 心律不整
  • 急性心肌梗塞
  • 心肌缺血
  • 其他用途
  • 全球心血管植入市場：按最終用戶、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 門診手術中心
  • 心臟中心
  • 全球心血管植入市場、冠狀動脈支架細分市場、類型、績效及預測（2019-2024 年、2024-2029 年及 2034 年）
  • 藥物釋放型支架
  • 裸金屬支架
  • 生物可吸收支架
  • 全球心血管植入市場，植入式心臟整流去顫器(ICD) 類型細分，績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 單腔ICD
  • 雙腔室ICD
  • 雙心室ICD
  • 全球心血管植入市場、心臟瓣膜細分市場、類型、績效及預測（2019-2024 年、2024-2029 年及 2034 年）
  • 人工心臟瓣膜
  • 生物心臟瓣膜
  • 經導管心臟瓣膜
  • 全球心血管植入市場，依植入式心臟心律調節器類型細分，績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 單腔心律調節器
  • 雙心腔型心律調節器
  • 雙心室心律調節器
  • 全球心血管植入市場心臟再同步治療 (CRT) 設備細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • CRT-P 設備（心律心律調節器）
  • CRT-D 裝置（心臟去顫器）
  • 全球心血管植入市場、周邊支架細分市場、類型、績效及預測（2019-2024 年、2024-2029 年及 2034 年）
  • 頸動脈支架
  • 腎動脈支架
  • 股動脈支架

第7章 區域和國家分析

  • 全球心血管植入市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球心血管植入市場：依國家、表現及預測（2019-2024 年、2024-2029 年及 2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 心血管植入市場：競爭格局
  • 心血管植入市場：公司簡介
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis
    • Edwards Lifesciences Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • WL Gore & Associates Inc.
  • Cook Medical Incorporated
  • Teleflex Incorporated
  • Kyoto Medical Planning Co. Ltd.
  • Abiomed Inc.
  • Livanova PLC
  • BIOTRONIK SE & Co. KG
  • CryoLife Inc.
  • Endologix Inc.
  • Sorin Group
  • Berlin Heart GmbH
  • REVA Medical LLC.
  • Syncardia Systems LLC
  • Elixir Medical Corporation
  • Fortimedix Surgical BV

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029年心血管植入市場：提供新機會的國家
  • 2029年心血管植入市場：細分領域帶來新機會
  • 2029年心血管植入市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r27629

Cardiovascular implants are medical devices surgically placed within the cardiovascular system to manage heart and vascular conditions. These devices are strategically inserted into the cardiovascular system to address conditions such as blocked arteries, irregular heart rhythms, or valve defects. The primary goal is to restore normal heart function and improve blood circulation.

The main types of products categorized under cardiovascular implants include coronary stents, implantable cardioverter defibrillators (ICD), heart valves, implanted cardiac pacemakers, cardiac resynchronization therapy (CRT) devices, and peripheral stents. A coronary stent is a small mesh tube inserted into a narrowed or blocked coronary artery to maintain its openness. Various materials, including metals and alloys, polymers, and biological materials, are used in the manufacturing of these implants. They find applications in treating conditions such as arrhythmias, acute myocardial infarction, myocardial ischemia, and others. These cardiovascular implants are utilized by various end-users, including hospitals, ambulatory surgical centers, and cardiac centers.

The cardiovascular implants market research report is one of a series of new reports from The Business Research Company that provides cardiovascular implants market statistics, including cardiovascular implants industry global market size, regional shares, competitors with a cardiovascular implants market share, detailed cardiovascular implants market segments, market trends and opportunities, and any further data you may need to thrive in the cardiovascular implants industry. This cardiovascular implants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cardiovascular implants market size has grown strongly in recent years. It will grow from $26.8 billion in 2024 to $28.86 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to aging population and cardiovascular risk, lifestyle-related cardiovascular risk factors, improvements in diagnostic technologies, growing awareness and screening programs, government initiatives for cardiovascular health.

The cardiovascular implants market size is expected to see strong growth in the next few years. It will grow to $36.69 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to personalized medicine approaches, focus on minimally invasive procedures, global collaboration in cardiovascular research, healthcare policy emphasis on preventive interventions, patient-centric cardiovascular care. Major trends in the forecast period include advancements in drug-eluting stents, rise of next-generation heart valves, increasing integration of artificial intelligence (ai), focus on minimally invasive implantation techniques, personalized and patient-specific implants, development of leadless pacemakers.

The increasing prevalence of heart disorders is anticipated to drive the growth of the cardiovascular implants market in the coming years. Heart disorders encompass a range of medical conditions impacting the heart and blood vessels, such as coronary artery disease, heart failure, arrhythmias, and valve disorders. The demand for cardiovascular implants, including stents and pacemakers, is fueled by the rise in heart diseases like coronary artery disease and heart failure, as these implants help support heart function and circulation in heart failure patients, regulate heart rhythm, and monitor heart activity. For example, in September 2024, the British Heart Foundation (BHF), a UK-based charity focused on funding research and raising awareness about heart and circulatory diseases, reported that approximately 7.6 million individuals in the UK suffer from heart and circulatory diseases. By 2030, this number could increase by 1 million, and by 2040, it may grow by an additional 2 million. Therefore, the growing prevalence of heart disorders is boosting the cardiovascular implants market.

The increase in the aging population is expected to drive the growth of the cardiovascular implants market in the future. The aging population reflects a demographic shift characterized by a higher proportion of individuals aged 60 and above in a population. Cardiovascular implants play a crucial role in managing and treating cardiovascular diseases prevalent in older individuals, contributing to improved quality of life, increased longevity, and overall better health outcomes. According to the World Health Organization in October 2022, globally, 1 in 6 individuals is projected to be 60 or older by 2030, and this number is expected to reach 2.1 billion elderly people by 2050. Therefore, the rise in the aging population is a key factor driving the growth of the cardiovascular implants market.

Leading companies in the cardiovascular implants market are intensifying their focus on incorporating advanced technology, including artificial intelligence (AI), to optimize market profits and enhance precision in patient care and treatment. Advancements in cardiac monitoring technology involve continuous tracking and recording of a patient's heart activity for the diagnosis and management of heart conditions. In June 2023, BIOTRONIK SE & Co. KG launched the BIOMONITOR IV implantable cardiac monitor (ICM), the first globally, combining SmartECG technology with artificial intelligence. This innovation reduces false-positive detections by 86% while retaining 98% accuracy in detecting real episodes. BIOMONITOR IV offers additional benefits, including extended battery life and wireless connectivity for smooth data transmission and remote monitoring, reducing the need for frequent in-person clinic visits.

In April 2023, Abbott Laboratories acquired Cardiovascular Systems Inc. for $890 million, aiming to enhance its solutions for treating vascular disease. This strategic acquisition makes Cardiovascular Systems Inc. a wholly owned subsidiary of Abbott and strengthens Abbott's position in providing innovative solutions for peripheral and coronary vascular disease.

Major companies operating in the cardiovascular implants market report are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, B. Braun Melsungen AG, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., Cook Medical Incorporated, Teleflex Incorporated, Kyoto Medical Planning Co. Ltd., Abiomed Inc., Livanova PLC, BIOTRONIK SE & Co. KG, CryoLife Inc., Endologix Inc., Sorin Group, Berlin Heart GmbH, REVA Medical LLC., Syncardia Systems LLC, Elixir Medical Corporation, Fortimedix Surgical B.V., AMG International GmbH, CHF Solutions Inc., Proxy Biomedical Ltd., Calon Cardio-Technology Ltd., InspireMD Inc., Neovasc Inc., Shree Pacetronix Ltd., Vascutek Ltd (Terumo Corporation)

North America was the largest region in the cardiovascular implants market in 2024. The regions covered in the cardiovascular implants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cardiovascular implants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cardiovascular implants market consists of sales of aneurysm stent-grafts, cardiac resynchronization therapy (CRT) devices, ventricular assist devices, and peripheral vascular stents. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cardiovascular Implants Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cardiovascular implants market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cardiovascular implants ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cardiovascular implants market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Coronary Stent; Implantable Cardioverter Defibrillator (ICD); Heart Valve; Implanted Cardiac Pacemaker; Cardiac Resynchronization Therapy (CRT) Devices; Peripheral Stent
  • 2) By Material: Metals and Alloys; Polymers; Biological Materials
  • 3) By Application: Arrhythmias; Acute Myocardial Infarction; Myocardial Ischemia; Other Applications
  • 4) By End-Users: Hospitals; Ambulatory Surgical Centers; Cardiac Centers
  • Subsegments:
  • 1) By Coronary Stent: Drug-Eluting Stents; Bare-Metal Stents; Bioabsorbable Stents
  • 2) By Implantable Cardioverter Defibrillator (ICD): Single-Chamber ICD; Dual-Chamber ICD; Biventricular ICD
  • 3) By Heart Valve: Mechanical Heart Valves; Biological Heart Valves; Transcatheter Heart Valves
  • 4) By Implanted Cardiac Pacemaker: Single-Chamber Pacemaker; Dual-Chamber Pacemaker; Biventricular Pacemaker
  • 5) By Cardiac Resynchronization Therapy (CRT) Devices: CRT-P Devices (Pacemakers); CRT-D Devices (Defibrillators)
  • 6) By Peripheral Stent: Carotid Artery Stents; Renal Artery Stents; Femoral Artery Stents
  • Companies Mentioned: Abbott Laboratories; Medtronic PLC; Boston Scientific Corporation; B. Braun Melsungen AG; Edwards Lifesciences Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cardiovascular Implants Market Characteristics

3. Cardiovascular Implants Market Trends And Strategies

4. Cardiovascular Implants Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Cardiovascular Implants Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Cardiovascular Implants PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Cardiovascular Implants Market Growth Rate Analysis
  • 5.4. Global Cardiovascular Implants Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Cardiovascular Implants Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Cardiovascular Implants Total Addressable Market (TAM)

6. Cardiovascular Implants Market Segmentation

  • 6.1. Global Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Coronary Stent
  • Implantable Cardioverter Defibrillator (ICD)
  • Heart Valve
  • Implanted Cardiac Pacemaker
  • Cardiac Resynchronization Therapy (CRT) Devices
  • Peripheral Stent
  • 6.2. Global Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Metals and Alloys
  • Polymers
  • Biological Materials
  • 6.3. Global Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Arrhythmias
  • Acute Myocardial Infarction
  • Myocardial Ischemia
  • Other Applications
  • 6.4. Global Cardiovascular Implants Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Centers
  • 6.5. Global Cardiovascular Implants Market, Sub-Segmentation Of Coronary Stent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug-Eluting Stents
  • Bare-Metal Stents
  • Bioabsorbable Stents
  • 6.6. Global Cardiovascular Implants Market, Sub-Segmentation Of Implantable Cardioverter Defibrillator (ICD), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Chamber ICD
  • Dual-Chamber ICD
  • Biventricular ICD
  • 6.7. Global Cardiovascular Implants Market, Sub-Segmentation Of Heart Valve, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Mechanical Heart Valves
  • Biological Heart Valves
  • Transcatheter Heart Valves
  • 6.8. Global Cardiovascular Implants Market, Sub-Segmentation Of Implanted Cardiac Pacemaker, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Chamber Pacemaker
  • Dual-Chamber Pacemaker
  • Biventricular Pacemaker
  • 6.9. Global Cardiovascular Implants Market, Sub-Segmentation Of Cardiac Resynchronization Therapy (CRT) Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • CRT-P Devices (Pacemakers)
  • CRT-D Devices (Defibrillators)
  • 6.10. Global Cardiovascular Implants Market, Sub-Segmentation Of Peripheral Stent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Carotid Artery Stents
  • Renal Artery Stents
  • Femoral Artery Stents

7. Cardiovascular Implants Market Regional And Country Analysis

  • 7.1. Global Cardiovascular Implants Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Cardiovascular Implants Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cardiovascular Implants Market

  • 8.1. Asia-Pacific Cardiovascular Implants Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cardiovascular Implants Market

  • 9.1. China Cardiovascular Implants Market Overview
  • 9.2. China Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cardiovascular Implants Market

  • 10.1. India Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cardiovascular Implants Market

  • 11.1. Japan Cardiovascular Implants Market Overview
  • 11.2. Japan Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cardiovascular Implants Market

  • 12.1. Australia Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cardiovascular Implants Market

  • 13.1. Indonesia Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cardiovascular Implants Market

  • 14.1. South Korea Cardiovascular Implants Market Overview
  • 14.2. South Korea Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cardiovascular Implants Market

  • 15.1. Western Europe Cardiovascular Implants Market Overview
  • 15.2. Western Europe Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cardiovascular Implants Market

  • 16.1. UK Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cardiovascular Implants Market

  • 17.1. Germany Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cardiovascular Implants Market

  • 18.1. France Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cardiovascular Implants Market

  • 19.1. Italy Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cardiovascular Implants Market

  • 20.1. Spain Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cardiovascular Implants Market

  • 21.1. Eastern Europe Cardiovascular Implants Market Overview
  • 21.2. Eastern Europe Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cardiovascular Implants Market

  • 22.1. Russia Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cardiovascular Implants Market

  • 23.1. North America Cardiovascular Implants Market Overview
  • 23.2. North America Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cardiovascular Implants Market

  • 24.1. USA Cardiovascular Implants Market Overview
  • 24.2. USA Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cardiovascular Implants Market

  • 25.1. Canada Cardiovascular Implants Market Overview
  • 25.2. Canada Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cardiovascular Implants Market

  • 26.1. South America Cardiovascular Implants Market Overview
  • 26.2. South America Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cardiovascular Implants Market

  • 27.1. Brazil Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cardiovascular Implants Market

  • 28.1. Middle East Cardiovascular Implants Market Overview
  • 28.2. Middle East Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cardiovascular Implants Market

  • 29.1. Africa Cardiovascular Implants Market Overview
  • 29.2. Africa Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cardiovascular Implants Market Competitive Landscape And Company Profiles

  • 30.1. Cardiovascular Implants Market Competitive Landscape
  • 30.2. Cardiovascular Implants Market Company Profiles
    • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Edwards Lifesciences Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Cardiovascular Implants Market Other Major And Innovative Companies

  • 31.1. W. L. Gore & Associates Inc.
  • 31.2. Cook Medical Incorporated
  • 31.3. Teleflex Incorporated
  • 31.4. Kyoto Medical Planning Co. Ltd.
  • 31.5. Abiomed Inc.
  • 31.6. Livanova PLC
  • 31.7. BIOTRONIK SE & Co. KG
  • 31.8. CryoLife Inc.
  • 31.9. Endologix Inc.
  • 31.10. Sorin Group
  • 31.11. Berlin Heart GmbH
  • 31.12. REVA Medical LLC.
  • 31.13. Syncardia Systems LLC
  • 31.14. Elixir Medical Corporation
  • 31.15. Fortimedix Surgical B.V.

32. Global Cardiovascular Implants Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cardiovascular Implants Market

34. Recent Developments In The Cardiovascular Implants Market

35. Cardiovascular Implants Market High Potential Countries, Segments and Strategies

  • 35.1 Cardiovascular Implants Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Cardiovascular Implants Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Cardiovascular Implants Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer